Application of Urine Nicotine and Cotinine Excretion Rates to Assessment of Nicotine Replacement in Light, Moderate, and Heavy Smokers Undergoing Transdermal Therapy
Authors:
- 1 June 1998
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 38 (6) , 510-516
Abstract
As part of a clinical trial investigating the level of nicotine replacement with different doses of transdermal therapy for smoking cessation, urine excretion rates of nicotine and cotinine were measured in 70 subjects while they were actively smoking (baseline) and for 6 consecutive inpatient days while they were receiving transdermal nicotine therapy. Subjects were stratified according to baseline smoking rate as light (10–15 cigarettes per day), moderate (16–30 cigarettes per day), or heavy (>30 cigarettes per day) smokers and randomly assigned to a daily 24‐hour patch delivering a transdermal nicotine dose of 0, 11, 22, or 44 mg. Steady‐state excretion rates of nicotine and cotinine were attained in 2 and 3 days, respectively, at all doses and were independent of smoking rate. Percentage replacement of nicotine was calculated by dividing steady‐state nicotine or cotinine excretion rates by their respective baseline excretion rates. Significant underreplacement occurred with the 11‐mg/day dose, particularly in moderate and heavy smokers (<50%). At a dose of 22 mg/day, nicotine replacement was still <100% in the majority of subjects. Only at a dose of 44 mg/day did mean replacement exceed 100% regardless of baseline smoking rate.Keywords
This publication has 12 references indexed in Scilit:
- Application of Serum Nicotine and Plasma Cotinine Concentrations to Assessment of Nicotine Replacement in Light, Moderate, and Heavy Smokers Undergoing Transdermal TherapyThe Journal of Clinical Pharmacology, 1998
- Varying Nicotine Patch Dose and Type of Smoking Cessation CounselingJAMA, 1995
- High-Dose Nicotine Patch TherapyJAMA, 1995
- Metabolism of nicotine to cotinine studied by a dual stable isotope methodClinical Pharmacology & Therapeutics, 1994
- Higher levels of nicotine in arterial than in venous blood after cigarette smokingDrug and Alcohol Dependence, 1993
- Metabolism of NicotineDrug Metabolism Reviews, 1991
- Clinical and pharmacokinetic properties of a transdermal nicotine patchClinical Pharmacology & Therapeutics, 1990
- Gas chromatographic determination of trans-3′-hydroxycotinine, a major metabolite of nicotine in smokersJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Quantification of cotinine in plasma and saliva by liquid chromatography.Clinical Chemistry, 1986
- Smokers of Low-Yield Cigarettes Do Not Consume Less NicotineNew England Journal of Medicine, 1983